Health care stocks were ailing Thursday afternoon despite a rally in the broader market.

With the exception of Eli Lilly ( LLY), which was up about 1 % to $32.68, and Procter & Gamble ( PG), which was inching up 0.4% to $48.67, widely held health care stocks were losing, while the Dow climbed 2.4% and the Nasdaq rose 3%.

Merck ( MRK) and Cardiome Pharma ( CRME) announced a partnership to develop a drug for atrial fibrillation, a deal that could result in Merck paying Cardiome more than $600 million. Merck shares were recently falling 1.2% to $26.44

Johnson & Johnson ( JNJ), which announced that the CYPHER stent outperformed the ENDEAVOR and TAXUS stents in a trial involving ischemia-driven target lesion revascularization and stent thrombosis, was down 0.1% to $51.39.

GlaxoSmithKline ( GSK) was losing 1.6% to $29.58.

Pfizer ( PFE) was down 0.4% to $13.43.

Novo Nordisk ( NVO) was down 0.5% to $43.77.

More from Investing

Quick Read: 3 Things for Investors to Know Before Wednesday's Trading Session

Quick Read: 3 Things for Investors to Know Before Wednesday's Trading Session

Replay: Jim Cramer on the Markets, Oil, General Electric, Zillow and Micron

Replay: Jim Cramer on the Markets, Oil, General Electric, Zillow and Micron

Pegasystems Founder Explains Why He Has One of the Hottest Tech Stocks Around

Pegasystems Founder Explains Why He Has One of the Hottest Tech Stocks Around

Adobe Isn't Just Going After Shopify With Its Latest Acquisition

Adobe Isn't Just Going After Shopify With Its Latest Acquisition

Experts Break Down GDPR Risks for Investors

Experts Break Down GDPR Risks for Investors